Standard Document
Fourth Edition
Microbiology

CLSI M57

Epidemiological Cutoff Values for Antifungal Susceptibility Testing

This CLSI document provides updated epidemiological cutoff values (ECVs) and quality control tables for antifungal susceptibility testing, developed according to CLSI M57 guidelines. The ECVs are valid only when generated using the reference broth dilution methods outlined in CLSI M27 and M38.

August 03, 2022
Gary W. Procop, MD, MS

{{FormatPrice(currentPrice)}}

Free

{{FormatPrice(nonMemberPrice)}} List Price
This is your member pricing.
Notify Me About New Editions
Abstract

Clinical and Laboratory Standards Institute document M57S—Epidemiological Cutoff Values for Antifungal Susceptibility Testing includes epidemiological cutoff values (ECVs) and quality control tables developed following the guidance in CLSI document M57. These ECVs are valid only when they are developed in accordance with CLSI document M57 and when minimal inhibitory concentrations or minimal effective concentrations are generated according to the reference broth dilution methods described in CLSI documents M27 and M38. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.

Overview of Changes

This document replaces the previous edition of the approved document, M59-Ed3, published in 2020. Several changes were made in this edition, including: (TABLE)

Product Details
M57SEd4E
1-56238-933-5
28
Authors
Gary W. Procop, MD, MS
Philippe J. Dufresne, PhD, RMCCM
Elizabeth Berkow, PhD
Sharon K. Cullen, BS, RAC
Jeff Fuller, PhD, FCCM, D(ABMM)
Kimberly E. Hanson, MD, MHS
Nicole M. Holliday, BA
Shawn R. Lockhart, PhD, D(ABMM), F(AAM)
Audrey N. Schuetz, MD, MPH, D(ABMM)
Paul E. Verweij, MD, FECMM
Nathan P. Wiederhold, PharmD
Adrian M. Zelazny, PhD, D(ABMM)
Abstract

Clinical and Laboratory Standards Institute document M57S—Epidemiological Cutoff Values for Antifungal Susceptibility Testing includes epidemiological cutoff values (ECVs) and quality control tables developed following the guidance in CLSI document M57. These ECVs are valid only when they are developed in accordance with CLSI document M57 and when minimal inhibitory concentrations or minimal effective concentrations are generated according to the reference broth dilution methods described in CLSI documents M27 and M38. Users should replace previously published tables with these new tables. Changes in the tables since the previous edition was published appear in boldface type.

Overview of Changes

This document replaces the previous edition of the approved document, M59-Ed3, published in 2020. Several changes were made in this edition, including: (TABLE)

M57SEd4E
1-56238-933-5
28
Authors
Gary W. Procop, MD, MS
Philippe J. Dufresne, PhD, RMCCM
Elizabeth Berkow, PhD
Sharon K. Cullen, BS, RAC
Jeff Fuller, PhD, FCCM, D(ABMM)
Kimberly E. Hanson, MD, MHS
Nicole M. Holliday, BA
Shawn R. Lockhart, PhD, D(ABMM), F(AAM)
Audrey N. Schuetz, MD, MPH, D(ABMM)
Paul E. Verweij, MD, FECMM
Nathan P. Wiederhold, PharmD
Adrian M. Zelazny, PhD, D(ABMM)